BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20502945)

  • 1. Platelet activation patterns in platelet size sub-populations: differential responses to aspirin in vitro.
    Mangalpally KK; Siqueiros-Garcia A; Vaduganathan M; Dong JF; Kleiman NS; Guthikonda S
    J Thromb Thrombolysis; 2010 Oct; 30(3):251-62. PubMed ID: 20502945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin.
    Guthikonda S; Lev EI; Patel R; DeLao T; Bergeron AL; Dong JF; Kleiman NS
    J Thromb Haemost; 2007 Mar; 5(3):490-6. PubMed ID: 17319904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets.
    Parker RI; Gralnick HR
    Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
    Guthikonda S; Alviar CL; Vaduganathan M; Arikan M; Tellez A; DeLao T; Granada JF; Dong JF; Kleiman NS; Lev EI
    J Am Coll Cardiol; 2008 Aug; 52(9):743-9. PubMed ID: 18718422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implications.
    Holmes MB; Sobel BE; Howard DB; Schneider DJ
    Thromb Res; 1999 Jul; 95(2):75-82. PubMed ID: 10418796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from, human platelets.
    Chronos NA; Wilson DJ; Janes SL; Hutton RA; Buller NP; Goodall AH
    Clin Sci (Lond); 1994 Nov; 87(5):575-80. PubMed ID: 7533066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pathological high shear exposure time on platelet activation and aggregation.
    Zhang T; Huang X; Gao X; Liu L; Chen D; Huan X; He C; Li Y
    Clin Hemorheol Microcirc; 2023; 84(2):125-139. PubMed ID: 37066902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-erythrocyte interactions enhance alpha(IIb)beta(3) integrin receptor activation and P-selectin expression during platelet recruitment: down-regulation by aspirin ex vivo.
    Vallés J; Santos MT; Aznar J; Martínez M; Moscardó A; Piñón M; Broekman MJ; Marcus AJ
    Blood; 2002 Jun; 99(11):3978-84. PubMed ID: 12010797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of ADP-induced platelet activation by aspirin and pravastatin: role of lectin-like oxidized low-density lipoprotein receptor-1, nitric oxide, oxidative stress, and inside-out integrin signaling.
    Marwali MR; Hu CP; Mohandas B; Dandapat A; Deonikar P; Chen J; Cawich I; Sawamura T; Kavdia M; Mehta JL
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1324-32. PubMed ID: 17538005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: Differences between peripheral and coronary angioplasty.
    Gremmel T; Xhelili E; Steiner S; Koppensteiner R; Kopp CW; Panzer S
    Atherosclerosis; 2014 Jan; 232(1):119-24. PubMed ID: 24401225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
    Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
    Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calpain regulation of cytoskeletal signaling complexes in von Willebrand factor-stimulated platelets. Distinct roles for glycoprotein Ib-V-IX and glycoprotein IIb-IIIa (integrin alphaIIbbeta3) in von Willebrand factor-induced signal transduction.
    Yuan Y; Dopheide SM; Ivanidis C; Salem HH; Jackson SP
    J Biol Chem; 1997 Aug; 272(35):21847-54. PubMed ID: 9268316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rac1-mediated signaling plays a central role in secretion-dependent platelet aggregation in human blood stimulated by atherosclerotic plaque.
    Dwivedi S; Pandey D; Khandoga AL; Brandl R; Siess W
    J Transl Med; 2010 Dec; 8():128. PubMed ID: 21134286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of ligand-occupied alpha IIb beta 3 in resting and activated human platelets determined by expression of a novel class of ligand-induced binding site recognized by monoclonal antibody AP6.
    Nurden P; Humbert M; Piotrowicz RS; Bihour C; Poujol C; Nurden AT; Kunicki TJ
    Blood; 1996 Aug; 88(3):887-99. PubMed ID: 8704246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of aspirin on thrombin stimulated platelet adhesion receptor expression and the role of neutrophils.
    Taylor ML; Ilton MK; Misso NL; Watkins DN; Hung J; Thompson PJ
    Br J Clin Pharmacol; 1998 Aug; 46(2):139-45. PubMed ID: 9723822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet alpha-granule secretion and its modification by SC-57101A, a GPIIb/IIIa antagonist.
    Ogawa T; Sugidachi A; Otsuguro K; Isobe T; Asai F
    Biochem Pharmacol; 2002 May; 63(10):1911-8. PubMed ID: 12034376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets.
    McKenzie ME; Malinin AI; Bell CR; Dzhanashvili A; Horowitz ED; Oshrine BR; Atar D; Serebruany VL
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):249-53. PubMed ID: 12695747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule release.
    Rinder CS; Student LA; Bonan JL; Rinder HM; Smith BR
    Blood; 1993 Jul; 82(2):505-12. PubMed ID: 7687162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.